| Sep 12 |
PTC Therapeutics: Positive HD Data Along With NDA Submission Brings Further Value
|
| Aug 28 |
PTC Therapeutics to Participate at Upcoming Investor Conferences
|
| Aug 26 |
PTC Therapeutics Has Upside Potential With Multiple Upcoming Catalysts, UBS Says
|
| Aug 26 |
PTC Therapeutics rises as UBS restarts coverage with buy rating
|
| Aug 19 |
PTC Therapeutics Stock Earns RS Rating Upgrade To 83
|
| Aug 10 |
PTC Therapeutics Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
| Aug 9 |
PTC Therapeutics, Inc. (PTCT) Q2 2024 Earnings Call Transcript
|
| Aug 8 |
PTC Therapeutics (PTCT) Reports Q2 Loss, Misses Revenue Estimates
|
| Aug 8 |
PTC Therapeutics reports Q2 results
|
| Aug 8 |
PTC Therapeutics: Q2 Earnings Snapshot
|
